Engraftment syndrome in breast cancer patients after stem cell transplantation is associated with poor long-term survival

Biology of Blood and Marrow Transplantation

Volumn 7, Issue 8, 2001, Pages 433-438

  Khan, Shahab A ^a   Gaa, Becky ^a   Pollock, Brad H ^a   Shea, Barbara ^a   Reddy, Vijay ^a   Wingard, Fohn R ^a   Moreb, Jan S ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Autoaggression syndrome; Autologous stem cell transplantation; Breast cancer; Engraftment syndrome; Graft versus host disease

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; GRANULOCYTE COLONY STIMULATING FACTOR; METHYLPREDNISOLONE; THIOTEPA;

ADRENAL GLAND; ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BRAIN; BREAST CANCER; CANCER GROWTH; CANCER MORTALITY; CANCER PATIENT; CANCER RECURRENCE; CANCER STAGING; CLINICAL OBSERVATION; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FEVER; FOLLOW UP; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INCIDENCE; LIVER; LUNG; MAJOR CLINICAL STUDY; RASH; STATISTICAL ANALYSIS; SURVIVAL; SURVIVAL TIME; VISCERA;

EID: 0034795686     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1083-8791(01)80010-0     Document Type: Article

References (26)

1. An update from the International Bone Marrow Transplant Registry and the Autologous Blood and Marrow Transplant Registry on current activity in hematopoietic stem cell transplantation
2. The biology of graft-versus-host reactions
3. Acute graft-versus-host disease in recipients of bone-marrow transplants from identical twin donors
4. Autologous graft-versus-host disease: Immunotherapy of breast cancer after bone marrow transplantation
5. Acute graft-vs-host disease. Development following autologous and syngeneic bone marrow transplantation
6. Evidence of a graft-versus-lymphoma effect associated with allogeneic bone marrow transplantation
7. Influence of acute and chronic graft-versus-host disease on relapse and survival after bone marrow transplantation from HLA-identical siblings as treatment of acute and chronic leukemia
8. Antileukemic effect of chronic graft-versus-host disease: Contribution to improved survival after allogeneic marrow transplantation
9. Increased risk of relapse in patients with chronic myelogenous leukemia given T-cell depleted marrow compared to methotrexate combined with cyclosporin or monotherapy for the prevention of graft-versus-host disease
10. How does bone-marrow transplantation cure leukaemia?
11. Comparison of autologous and allogeneic bone marrow transplantation for treatment of high-risk refractory acute lymphoblastic leukemia
12. Phase I trial of cyclosporine-induced autologous graft-versus-host disease in patients with multiple myeloma undergoing high-dose chemotherapy with autologous stem-cell rescue
13. Cyclosporine-induced autologous graft-versus-host disease following autologous blood stem cell transplantation for lymphoma
14. Characterization of the autoreactive T cell repertoire in cyclosporin-induced syngeneic graft-versus-host disease. A highly conserved repertoire mediates autoaggression
15. Phase I trial of interferon gamma to potentiate cyclosporin-induced graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer
16. Immunotherapy with interleukin-2 and α-interferon after IL-2-activated hematopoietic stem cell transplantation for breast cancer
17. Close simulation of acute graft-versus-host disease by interleukin-2 administered after autologous bone marrow transplantation for hematologic malignancy
18. Increased frequency of autoaggression syndrome associated with autologous stem cell transplantation in breast cancer patients
19. Autoaggression syndrome resembling acute graft-versus-host disease grade IV after autologous peripheral blood stem cell transplantation for breast cancer
20. Engraftment syndrome in autologous bone marrow peripheral stem cell transplant
21. Clinical evidence for an engraftment syndrome associated with early and steep neutrophil recovery after autologous blood stem cell transplantation
22. Induction of graft-versus-host disease after autologous bone marrow transplantation
23. HLA class II sublocus expression in benign and malignant breast epithelium
24. Presence of HLA-D/DR antigens on the membrane of breast tumour cells
25. Phase I trial of intravenous cyclosporine to induce graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer
26. Specificity of effector T lymphocytes in autologous graft-versus-host disease: Role of the major histocompatibility complex class II invariant chain peptide